APA (7th ed.) Citation

Griffett, K., & Burris, T. P. (2016). Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease. Biochemical & Biophysical Research Communications, 479(3), 424. https://doi.org/10.1016/j.bbrc.2016.09.036

Chicago Style (17th ed.) Citation

Griffett, Kristine, and Thomas P. Burris. "Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease." Biochemical & Biophysical Research Communications 479, no. 3 (2016): 424. https://doi.org/10.1016/j.bbrc.2016.09.036.

MLA (9th ed.) Citation

Griffett, Kristine, and Thomas P. Burris. "Promiscuous Activity of the LXR Antagonist GSK2033 in a Mouse Model of Fatty Liver Disease." Biochemical & Biophysical Research Communications, vol. 479, no. 3, 2016, p. 424, https://doi.org/10.1016/j.bbrc.2016.09.036.